Skip to content

Study to evaluate effect of ten-on-ten syrup in children with Attention Deficit Hyperactivity Disorder (ADHD)

A prospective, interventional, randomised, two-arm, single centre study to evaluate the effect of ten-on-ten syrup on children with attention deficit hyperactivity disorder (ADHD). - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068254
Enrollment
60
Registered
2024-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F90- Attention-deficit hyperactivity disorders

Interventions

Intervention1: ten-on-ten syrup: Ten-on-ten syrup will be given to ADHD diagnosed children for duration of 6 months. The dosage of the medication will be as followed: 5 ml twice daily for 180 days (fo

Sponsors

Herba Neuva Implex Pvt. Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged between 6-12 years who are diagnosed with mild to moderate ADHD. 2. Children irrespective of gender, religion, socio-economic status. 3. Patient’s parent/legal guardian who is ready to sign Consent Form.

Exclusion criteria

Exclusion criteria: 1. Children less than 6 years and more than 12 years. 2. Children with Epilepsy and taking anti-epileptic medications. 3. Children with severe comorbid conditions like oppositional defiant disorder, conduct disorder, substance abuse, anxiety disorder. 4. History of hypersensitivity or food allergy to components of omega 3/6, ( fish like salmon, mackerel, tuna, sardines, shellfish or flaxseed oil, Nuts and seeds such as flaxseed, chia seeds, and walnuts), herbal supplements shall be elicited on medical history. 5. Children taking anticoagulant medications like warfarin or aspirin. 6. Children with chronic systemic disease or other major psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
Improvement in signs and symptoms of ADHD assessed using Vanderbilt assessment scale-parent version.Timepoint: 24 weeks

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Omkar Hajirnis

Bhaktivedanta Hospital and Research Institute

dr.omkar@gmail.com9869271683

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026